Cargando…
Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use
Evidence is increasing that disturbances in the gut microbiome may play a significant role in the etiology of obesity and type 2 diabetes. The short chain fatty acid butyrate, a major end product of the bacterial fermentation of indigestible carbohydrates, is reputed to have anti‐inflammatory proper...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541926/ https://www.ncbi.nlm.nih.gov/pubmed/35856338 http://dx.doi.org/10.1111/obr.13498 |